ADAPTIVE BIOTECHNOLOGIES COR holding history
As of Nov. 6, 2026 (UTC)
| June 30, 2025 | 142,257 | $1,657,294 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 13, 2025 |
| Sept. 30, 2025 | 291,197 | $4,356,307 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 325,767 | $5,290,456 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 116,051 | $1,610,788 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2026 |
| June 30, 2026 | 102,457 | $2,197,703 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 4, 2026 |
5 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.